 

Active ingredient: Benzphetamine Hydrochloride 

 

Form/Route: Tablet/Oral 

 

Recommended studies: 

 

Benzphetamine Hydrochloride Tablets, is a DESI-effective drug product without known 
bioequivalence problems. Therefore, in-vivo bioequivalence testing is not requested. 
Comparative dissolution testing on 12 dosage units of all strengths of the test and reference 
products is requested. You may request a waiver of in-vivo bioequivalence study requirements on 
this product under 21 CFR 320.22(c). 
______________________________________________________________________________ 

 

Analytes to measure: Not Applicable 

 

Bioequivalence based on (90% CI): Not Applicable 

 

Waiver request of in-vivo testing: 50 mg 

 

Dissolution test method and sampling times: 

 

Please note that a Dissolution Methods Database is available to the public at the OGD website 
at http://www.fda.gov/cder/ogd/index.htm. Please find the dissolution information for this 
product at this website. Please conduct comparative dissolution testing on 12 dosage units each 
of all strengths of the test and reference products. Specifications will be determined upon review 
of the application. 


